Concepedia

Publication | Closed Access

Safety and efficacy of high-dose rhesus-human reassortant rotavirus vaccines--report of the National Multicenter Trial. United States Rotavirus Vaccine Efficacy Group.

308

Citations

0

References

1996

Year

Margaret B. Rennels, Roger I. Glass, Penelope H. Dennehy, D I Bernstein, Michael E. Pichichero, Edward T. Zito, M. Mack, Bruce L. Davidson, A Z Kapikian
PubMed

Abstract

RRV-TV is highly protective against very severe, dehydrating rotavirus gastroenteritis.